As we have mentioned that FGF21 could improve DCM by the activation of ERK (20) and AKT (21) pathway, thus, whether FGF21 could ameliorate DCM through inducing DNA methylation on IGFBP3 requires further investigation. The gene discussed is FGF21; the disease is familial dilated cardiomyopathy.